ViaGen, Inc. is partnering with the Monash Institute of Melbourne, Australia, to harness equine stem cells to repair tendon, ligament, cartilage, and bone damage in horses.


Dr. Paul Verma of the Monash Institute of Medical Research is working to develop equine embryonic stem cell lines, with the goal of creating a “bank” of stem cells genetically matched to individual horses with no risk of rejection.


Current stem cell therapies use fat or bone marrow cells that are then grown into the required tissue cells. This process can take up to three weeks.


For more information, contact ViaGen; 12357-A Riata Trace Parkway, Suite 100, Austin, Texas 78727; 888/884-2436; www.viagen.com

Create a free account with TheHorse.com to view this content.

TheHorse.com is home to thousands of free articles about horse health care. In order to access some of our exclusive free content, you must be signed into TheHorse.com.

Start your free account today!

Already have an account?
and continue reading.